Benefit in symptoms, functional outcomes remains to be seen for HU6
News and commentary from the endocrinology world
Bowel preparation protocols appeared protective in small study
Other than staying on drug, there's no evidence-based strategy to maintain weight loss
Novo Nordisk needs to cut prices, says Sen. Bernie Sanders
Nearly 10% of those surveyed reported severe obesity
Researcher discusses weight outcomes for those taking semaglutide or liraglutide
More noteworthy research from the EASD 2024 meeting
Regulators will need to closely watch this new frontier
But significant weight loss reported for both
Saxenda group six times more likely to lose at least 5% of BMI
No link found in nationwide data from Sweden and Denmark and in analysis of STEP trials